ES485116A1 - Procedimiento para la obtencion de plasma sanguineo estable y esteril - Google Patents

Procedimiento para la obtencion de plasma sanguineo estable y esteril

Info

Publication number
ES485116A1
ES485116A1 ES485116A ES485116A ES485116A1 ES 485116 A1 ES485116 A1 ES 485116A1 ES 485116 A ES485116 A ES 485116A ES 485116 A ES485116 A ES 485116A ES 485116 A1 ES485116 A1 ES 485116A1
Authority
ES
Spain
Prior art keywords
plasma
translation
machine
legally binding
google translate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES485116A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SERRA DE DALMASES FAUSTO
Original Assignee
SERRA DE DALMASES FAUSTO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SERRA DE DALMASES FAUSTO filed Critical SERRA DE DALMASES FAUSTO
Priority to ES485116A priority Critical patent/ES485116A1/es
Publication of ES485116A1 publication Critical patent/ES485116A1/es
Expired legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procedimiento para la obtención de plasma sanguíneo estable y estéril, particularmente destinado a la alimentación humana y animal, caracterizado por comprender las etapas de: estabilización de la sangre fresca mediante su tratamiento con un preservativo del tipo de dióxido de azufre o sulfitos; descomposición de la sangre estabilizada en plasma y corpúsculos; tratamiento del plasma con un agente oxidante, a los efectos de destruir el preservativo estabilizante y de asegurar la obtención de una solución de plasma estéril; secado de dicho plasma estéril.
ES485116A 1979-10-17 1979-10-17 Procedimiento para la obtencion de plasma sanguineo estable y esteril Expired ES485116A1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES485116A ES485116A1 (es) 1979-10-17 1979-10-17 Procedimiento para la obtencion de plasma sanguineo estable y esteril

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES485116A ES485116A1 (es) 1979-10-17 1979-10-17 Procedimiento para la obtencion de plasma sanguineo estable y esteril

Publications (1)

Publication Number Publication Date
ES485116A1 true ES485116A1 (es) 1980-04-16

Family

ID=8479118

Family Applications (1)

Application Number Title Priority Date Filing Date
ES485116A Expired ES485116A1 (es) 1979-10-17 1979-10-17 Procedimiento para la obtencion de plasma sanguineo estable y esteril

Country Status (1)

Country Link
ES (1) ES485116A1 (es)

Similar Documents

Publication Publication Date Title
SE8102193L (sv) Terapeutiskt aktiv organisk forening och dess anvendning
DE3689909D1 (de) Verwendung eines GHL-Cu enthaltenden Stoffes zur Herstellung eines Arzneimittels für Wunden.
IL76119A (en) Device for initiating reperfusion treatment when heart attack symptoms are present
GR3019514T3 (en) Pharmaceutical preparation for the treatment of prolonged coagulation time
FR2523956B1 (es)
HK59984A (en) A process for the preparation of a sterile injectable physiologically acceptable solution of an x-ray contrast agent and solutions of the x-ray contrast agent and a buffer
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
DK47089D0 (da) Middel med oedelaeggende virkning paa maligne tumorer, fremgangsmaade til fremstilling af saadanne midler og anvendelse af disse til terapeutisk behandling af cancer
DE3065342D1 (en) Chromium acetylacetonate as a dietary supplement and pharmaceutical agent
KR900002802A (ko) 면역억제제로서의 트랜스글루타미나제의 용도
KR890004690A (ko) 당뇨병의 치료를 위한 베자피브레이드의 용도
HU9300467D0 (en) Mixture of medical effect containing glutatione and antocithane derivatives
ES485116A1 (es) Procedimiento para la obtencion de plasma sanguineo estable y esteril
Djordjević et al. Studies on the hematologic effects of long-term, low-dose microwave exposure
JPS5551012A (en) Application of germanium(ge) in hair multiplication
GB2008944A (en) Copper compositions for topical application in the treatment of copper deficiency in animals
PT96828A (pt) Processo para a preparacao de um agente para a terapia de gangrena diabetica,contendo o factor xiii de coagulacao do sangue
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
ES469749A1 (es) Un procedimiento para la preparacion de una formulacion far-maceutica de una droga de notroimidazol.
DE3276786D1 (en) Medical process and preparation
GB2000968A (en) Killed trypanosoma vaccine and immunologically active components of trypanosoma
SU1113093A1 (ru) Способ лечени остеомиелита
Milner The office treatment of minor chemical skin burns
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
JPS5732226A (en) Substance capable of preventing suppuration and aggravation by direct application to affected part just after surgical operation or exodontia or exposed affected part of external wound or athlete's foot